Publikationen von F. Holsboer

Kimura, M.; Müller-Preuss, P.; Wiesner, E.; Höhne, A.; Holsboer, F.: Depression and sleep: a comparative study on EEG activity after different antidepressant treatments in mice. Journal of Sleep Research 17 (Suppl. 1), S. 202 - 203 (2008)

Lu, A.; Steiner, M. A.; Whittle, N.; Vogl, A. M.; Walser, S. M.; Ableitner, M.; Refojo, D.; Ekker, M.; Rubenstein, J. L.; Stalla, G. K. et al.; Singewald, N.; Holsboer, F.; Wotjak, C. T.; Wurst, W.; Deussing, J. M.: Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Molecular Psychiatry 13 (11), S. 1028 - 1042 (2008)

Sillaber, I.; Panhuysen, M.; Henniger, M. S. H.; Ohl, F.; Kühne, C.; Pütz, B.; Pohl, T.; Deussing, J. M.; Paez-Pereda, M.; Holsboer, F.: Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology 200 (4), S. 557 - 572 (2008)

Wöhr, M.; Dahlhoff, M.; Wolf, E.; Holsboer, F.; Schwarting, R. K. W.; Wotjak, C. T.: Effects of Genetic Background, Gender, and Early Environmental Factors on Isolation-Induced Ultrasonic Calling in Mouse Pups: An Embryo-Transfer Study. Behavior Genetics 38 (6), S. 579 - 595 (2008)

Hanstein, R.; Lu, A.; Wurst, W.; Holsboer, F.; Deussing, J. M.; Clement, A. B.; Behl, C.: TRANSGENIC OVEREXPRESSION OF CORTICOTROPIN RELEASING HORMONE PROVIDES PARTIAL PROTECTION AGAINST NEURODEGENERATION IN AN IN VIVO MODEL OF ACUTE EXCITOTOXIC STRESS. Neuroscience 156 (3), S. 712 - 721 (2008)

Keck, M. E.; Kern, N.; Erhardt, A.; Unschuld, P. G.; Ising, M.; Salyakina, D.; Müller, M. B.; Knorr, C. C.; Lieb, R.; Hohoff, C. et al.; Krakowitzky, P.; Maier, W.; Bandelow, B.; Fritze, J.; Deckert, J.; Holsboer, F.; Müller-Myhsok, B.; Binder, E. B.: Combined Effects of Exonic Polymorphisms in CRHR1 and AVPR1B Genes in a Case/Control Study for Panic Disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 147B (7), S. 1196 - 1204 (2008)

Friess, E.; Schmid, D.; Modell, S.; Brunner, H.; Lauer, C. J.; Holsboer, F.; Ising, M.: Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders. Journal of Psychiatric Research 42 (14), S. 1154 - 1162 (2008)

Schmid, D. A.; Brunner, H.; Lauer, C. J.; Uhr, M.; Yassouridis, A.; Holsboer, F.; Friess, E.: Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression. Journal of Psychiatric Research 42 (12), S. 991 - 999 (2008)

Ströhle, A.; Scheel, M.; Modell, S.; Holsboer, F.: Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder. Journal of Psychiatric Research 42 (14), S. 1185 - 1188 (2008)

Kronsbein, H. C.; Jastorff, A. M.; Maccarrone, G.; Stalla, G.; Wurst, W.; Holsboer, F.; Turck, C. W.; Deussing, J. M.: CRHR1-dependent effects on protein expression and posttranslational modification in AtT-20 cells. Molecular and Cellular Endocrinology 292 (1-2), S. 1 - 10 (2008)

Heck, A.; Lieb, R.; Unschuld, P.; Ellgas, A.; Pfister, H.; Lucae, S.; Erhardt, A.; Himmerich, H.; Horstmann, S.; Kloiber, S. et al.; Ripke, S.; Müller-Myhsok, B.; Bettecken, T.; Uhr, M.; Holsboer, F.; Ising, M.: Evidence for associations between PDE4D polymorphisms and a subtype of neuroticism. Molecular Psychiatry 13 (9), S. 831 - 832 (2008)

Reckow, S.; Gormanns, P.; Holsboer, F.; Turck, C. W.: Psychiatric disorders biomarker identification: from proteomics to systems biology. Pharmacopsychiatry 41 (Suppl. 1), S. S70 - S77 (2008)

Ambrosius, U.; Lietzenmaier, S.; Wehrle, R.; Wichniak, A.; Kalus, S.; Winkelmann, J.; Bettecken, T.; Holsboer, F.; Yassouridis, A.; Friess, E.: Heritability of sleep electroencephalogram. Biological Psychiatry 64 (4), S. 344 - 348 (2008)

Friess, E.; Modell, S.; Brunner, H.; Tagaya, H.; Lauer, C. J.; Holsboer, F.; Ising, M.: The Munich vulnerability study on affective disorders: microstructure of sleep in high-risk subjects. European Archives of Psychiatry and Clinical Neuroscience 258 (5), S. 285 - 291 (2008)

Horstmann, S.; Lucae, S.; Menke, A.; Ising, M.; Müller-Myhsok, B.; Holsboer, F.; Binder, E.: Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients. European Neuropsychopharmacology 18 (Suppl. 4), S. S214 - S215 (2008)

Kloiber, S.; Kohli, M. A.; Brueckl, T.; Ising, M.; Uhr, M.; Menke, A.; Müller-Myhsok, B.; Holsboer, F.; Lucae, S.: Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression. European Neuropsychopharmacology 18 (Suppl. 4), S. S296 - S296 (2008)

Reppermund, S.; Lieb, R.; Heck, A.; Ellgas, A.; Lucae, S.; Holsboer, F.; Ising, M.: The role of the dopamine beta-hydroxylase (DBH) gene in human cognitive function. European Neuropsychopharmacology 18 (Suppl. 4), S. S281 - S281 (2008)

Schormair, B.; Kemlink, D.; Roeske, D.; Eckstein, G.; Xiong, L.; Lichtner, P.; Ripke, S.; Trenkwalder, C.; Zimprich, A.; Stiasny-Kolster, K. et al.; Oertel, W.; Bachmann, C. G.; Paulus, W.; Högl, B.; Frauscher, B.; Gschliesser, V.; Poewe, W.; Peglau, I.; Vodicka, P.; Vavrova, J.; Sonka, K.; Nevsimalova, S.; Montplaisir, J.; Turecki, G.; Rouleau, G.; Gieger, C.; Illig, T.; Wichmann, H. E.; Holsboer, F.; Mueller-Myhsok, B.; Meitinger, T.; Winkelmann, J.: PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nature Genetics 40 (8), S. 946 - 948 (2008)

Zimmermann, P.; Kloiber, S.; Brueckl, T.; Pfister, H.; Wittchen, H. U.; Holsboer, F.; Ising, M.; Lieb, R.: Relationship of variations in the leptin receptor (LEPR) gene and depressive symptoms is moderated by severe trauma. European Neuropsychopharmacology 18 (Suppl. 4), S. S319 - S319 (2008)

Ableitner, M.; Kuhn, R.; Wurst, W.; Holsboer, F.; Deussing, J. M.: Generating cre-mouse lines to analyze the corticotropin-releasing-hormone system. International Journal of Neuropsychopharmacology 11 (Suppl. 1), S. 117 - 117 (2008)